(Exact name of registrant as specified in its charter) |
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
(Address of Principal Executive Offices) | (Zip Code) |
Title of Each Class | Trading Symbol | Name of Each Exchange on which Registered | ||||||
Exhibit No. | Description | |||||||
Unaudited Pro Forma Condensed Consolidated Financial Information | ||||||||
Press Release, dated July 1, 2024 | ||||||||
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
BABCOCK & WILCOX ENTERPRISES, INC. | |||||||||||
July 1, 2024 | By: | /s/ Louis Salamone | |||||||||
Louis Salamone | |||||||||||
Executive Vice President, Chief Financial Officer (Principal Accounting Officer and Duly Authorized Representative) |
PAGE | |||||
Unaudited Pro Forma Condensed Consolidated Balance Sheet as of March 31, 2024 | |||||
Unaudited Pro Forma Condensed Consolidated Statement of Operations for the Three Months Ended March 31, 2024 | |||||
Unaudited Pro Forma Condensed Consolidated Statement of Operations and Comprehensive Income for the Year Ended December 31, 2023 | |||||
Notes to the Pro Forma Condensed Consolidated Balance Sheet as of March 31, 2024 | |||||
Notes to the Pro Forma Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2024 and the Year Ended December 31, 2023 | |||||
(in thousands, except per share amounts) | Company Historical | Pro Forma Adjustments | Condensed Consolidated Pro Forma | ||||||||||||||
Cash and cash equivalents | $ | 43,881 | $ | 82,997 | $ | 126,878 | |||||||||||
Current restricted cash and cash equivalents | 16,935 | — | 16,935 | ||||||||||||||
Accounts receivable – trade, net | 124,398 | (10,550) | 113,848 | ||||||||||||||
Accounts receivable – other | 29,930 | (352) | 29,578 | ||||||||||||||
Contracts in progress | 107,431 | (12,387) | 95,044 | ||||||||||||||
Inventories, net | 112,407 | (6,886) | 105,521 | ||||||||||||||
Other current assets | 22,975 | (148) | 22,827 | ||||||||||||||
Current assets held for sale | 24,266 | — | 24,266 | ||||||||||||||
Total current assets | 482,223 | 52,674 | 534,897 | ||||||||||||||
Net property, plant and equipment and finance leases | 78,514 | (1,744) | 76,770 | ||||||||||||||
Goodwill | 100,655 | (16,410) | 84,245 | ||||||||||||||
Intangible assets, net | 42,816 | (10,526) | 32,290 | ||||||||||||||
Right-of-use assets | 28,641 | (182) | 28,459 | ||||||||||||||
Long-term restricted cash | 41,636 | — | 41,636 | ||||||||||||||
Deferred tax assets | 2,094 | — | 2,094 | ||||||||||||||
Other assets | 18,944 | (346) | 18,598 | ||||||||||||||
Total assets | $ | 795,523 | $ | 23,466 | $ | 818,989 | |||||||||||
Accounts payable | $ | 129,535 | $ | (3,696) | $ | 125,839 | |||||||||||
Accrued employee benefits | 11,246 | (1,244) | 10,002 | ||||||||||||||
Advance billings on contracts | 74,861 | (92) | 74,769 | ||||||||||||||
Accrued warranty expense | 7,160 | (526) | 6,634 | ||||||||||||||
Current Portion: | |||||||||||||||||
Financing lease liabilities | 1,400 | — | 1,400 | ||||||||||||||
Operating lease liabilities | 3,804 | (60) | 3,744 | ||||||||||||||
Other accrued liabilities | 65,268 | (13,157) | 52,111 | ||||||||||||||
Loans payable | 4,473 | — | 4,473 | ||||||||||||||
Current liabilities held for sale | 35,179 | — | 35,179 | ||||||||||||||
Total current liabilities | 332,926 | (18,775) | 314,151 | ||||||||||||||
Senior notes | 338,388 | — | 338,388 | ||||||||||||||
Loans payable, net of current portion | 98,727 | — | 98,727 | ||||||||||||||
Pension and other postretirement benefit liabilities | 172,174 | — | 172,174 | ||||||||||||||
Finance lease liabilities, net of current portion | 25,839 | — | 25,839 | ||||||||||||||
Operating lease liabilities, net of current portion | 25,990 | (122) | 25,868 | ||||||||||||||
Deferred tax liability | 12,991 | (1,015) | 11,976 | ||||||||||||||
Other non-current liabilities | 10,955 | (1,879) | 9,076 | ||||||||||||||
Total liabilities | 1,017,990 | (21,791) | 996,199 | ||||||||||||||
Stockholders' deficit: | |||||||||||||||||
Preferred stock, par value $0.01 per share, authorized shares of 20,000; issued and outstanding shares of 7,669 at both March 31, 2024 and December 31, 2023 | 77 | — | 77 | ||||||||||||||
Common stock, par value $0.01 per share, authorized shares of 500,000; issued and outstanding shares of 89,480 and 89,449 at March 31, 2024 and December 31, 2023, respectively | 5,149 | — | 5,149 | ||||||||||||||
Capital in excess of par value | 1,547,671 | — | 1,547,671 | ||||||||||||||
Treasury stock at cost, 2,139 shares at March 31, 2024 and December 31, 2023, respectively | (115,164) | — | (115,164) | ||||||||||||||
Accumulated deficit | (1,591,489) | 44,057 | (1,547,432) | ||||||||||||||
Accumulated other comprehensive loss | (69,255) | 1,200 | (68,055) | ||||||||||||||
Stockholders' deficit attributable to shareholders | (223,011) | 45,257 | (177,754) | ||||||||||||||
Non-controlling interest | 544 | — | 544 | ||||||||||||||
Total stockholders' deficit | (222,467) | 45,257 | (177,210) | ||||||||||||||
Total liabilities and stockholders' deficit | $ | 795,523 | $ | 23,466 | $ | 818,989 |
(in thousands, except per share amounts) | Company Historical | Pro Forma Adjustments | Condensed Consolidated Pro Forma | ||||||||||||||
Revenues | $ | 207,556 | $ | (17,518) | $ | 189,095 | |||||||||||
Costs and expenses: | |||||||||||||||||
Cost of operations | 159,075 | (12,963) | 145,169 | ||||||||||||||
Selling, general and administrative expenses | 41,438 | (3,302) | 38,136 | ||||||||||||||
Restructuring activities | 1,580 | — | 1,580 | ||||||||||||||
Research and development costs | 1,081 | — | 1,081 | ||||||||||||||
Loss (gain) on asset disposals, net | 53 | (6) | 47 | ||||||||||||||
Total costs and expenses | 203,227 | (16,271) | 186,013 | ||||||||||||||
Operating income | 4,329 | (1,247) | 3,082 | ||||||||||||||
Other (expense) income: | |||||||||||||||||
Interest expense | (12,834) | 27 | (12,807) | ||||||||||||||
Interest income | 307 | (149) | 158 | ||||||||||||||
Loss on debt extinguishment | (5,071) | — | (5,071) | ||||||||||||||
Benefit plans, net | 96 | — | 96 | ||||||||||||||
Foreign exchange | (1,333) | — | (1,333) | ||||||||||||||
Total other expense, net | (18,835) | (122) | (18,957) | ||||||||||||||
Loss before income tax expense | (14,506) | (1,369) | (15,875) | ||||||||||||||
Income tax expense | 1,293 | — | 1,293 | ||||||||||||||
Loss from continuing operations | (15,799) | (1,369) | (17,168) | ||||||||||||||
Loss from discontinued operations, net of tax | (992) | — | (992) | ||||||||||||||
Net loss | (16,791) | (1,369) | (18,160) | ||||||||||||||
Net income attributable to non-controlling interest | (42) | — | (42) | ||||||||||||||
Net loss attributable to stockholders | (16,833) | (1,369) | (18,202) | ||||||||||||||
Less: Dividend on Series A preferred stock | 3,714 | — | 3,714 | ||||||||||||||
Net loss attributable to stockholders of common stock | $ | (20,547) | $ | (1,369) | $ | (21,916) | |||||||||||
Basic and diluted loss per share | |||||||||||||||||
Continuing operations | $ | (0.22) | $ | (0.23) | |||||||||||||
Discontinued operations | (0.01) | (0.01) | |||||||||||||||
Basic and diluted loss per share | $ | (0.23) | $ | (0.24) | |||||||||||||
Basic and diluted shares used in the computation of loss per share | 89,479 | 89,479 | |||||||||||||||
Other Comprehensive Loss | |||||||||||||||||
Net loss | $ | (16,791) | $ | (1,369) | $ | (18,160) | |||||||||||
Other comprehensive (loss) income: | |||||||||||||||||
Currency translation adjustment | (3,125) | 1,382 | (1,743) | ||||||||||||||
Pension and post retirement adjustments, net of tax | 231 | — | 231 | ||||||||||||||
Total other comprehensive loss | (2,894) | 1,382 | (1,512) | ||||||||||||||
Total comprehensive loss | (19,685) | 13 | (19,672) | ||||||||||||||
Comprehensive income attributable to non-controlling interest | (67) | — | (67) | ||||||||||||||
Comprehensive loss attributable to stockholders | $ | (19,752) | $ | 13 | $ | (19,739) |
(in thousands, except per share amounts) | Company Historical | Pro Forma Adjustments | Condensed Consolidated Pro Forma | ||||||||||||||
Revenues | $ | 999,354 | $ | (96,411) | $ | 902,943 | |||||||||||
Costs and expenses: | |||||||||||||||||
Cost of operations | 775,267 | (69,515) | 705,752 | ||||||||||||||
Selling, general and administrative expenses | 191,465 | (12,522) | 178,943 | ||||||||||||||
Restructuring activities | 4,222 | — | 4,222 | ||||||||||||||
Research and development costs | 8,444 | — | 8,444 | ||||||||||||||
Gain on sale of business | — | (45,257) | (45,257) | ||||||||||||||
Loss on asset disposals, net | 57 | (30) | 27 | ||||||||||||||
Total costs and expenses | 979,455 | (127,324) | 852,131 | ||||||||||||||
Operating income | 19,899 | 30,913 | 50,812 | ||||||||||||||
Other (expense) income: | |||||||||||||||||
Interest expense | (49,895) | — | (49,895) | ||||||||||||||
Interest income | 1,192 | (74) | 1,118 | ||||||||||||||
Benefit plans, net | (37,505) | — | (37,505) | ||||||||||||||
Foreign exchange | (2,507) | — | (2,507) | ||||||||||||||
Other expense – net | (1,336) | — | (1,336) | ||||||||||||||
Total other expense, net | (90,051) | (74) | (90,125) | ||||||||||||||
Loss before income tax expense | (70,152) | 30,839 | (39,313) | ||||||||||||||
Income tax expense | 8,481 | 658 | 9,139 | ||||||||||||||
Loss from continuing operations | (78,633) | 30,181 | (48,452) | ||||||||||||||
Loss from discontinued operations, net of tax | (118,338) | — | (118,338) | ||||||||||||||
Net loss | (196,971) | 30,181 | (166,790) | ||||||||||||||
Net income attributable to non-controlling interest | (237) | — | (237) | ||||||||||||||
Net loss attributable to stockholders | (197,208) | 30,181 | (167,027) | ||||||||||||||
Less: Dividend on Series A preferred stock | 14,858 | — | 14,858 | ||||||||||||||
Net loss attributable to stockholders of common stock | $ | (212,066) | $ | 30,181 | $ | (181,885) | |||||||||||
Basic and diluted loss per share | |||||||||||||||||
Continuing operations | $ | (1.05) | $ | (0.71) | |||||||||||||
Discontinued operations | (1.33) | (1.33) | |||||||||||||||
Basic and diluted loss per share | $ | (2.38) | $ | (2.04) | |||||||||||||
Basic and diluted shares used in the computation of loss per share | 89,011 | 89,011 | |||||||||||||||
Other Comprehensive Loss | |||||||||||||||||
Net loss | $ | (196,971) | $ | 30,181 | $ | (166,790) | |||||||||||
Other comprehensive (loss) income: | |||||||||||||||||
Currency translation adjustment | 5,555 | (1,642) | 3,913 | ||||||||||||||
Pension and post retirement adjustments, net of tax | 870 | — | 870 | ||||||||||||||
Total other comprehensive (loss) income | 6,425 | (1,642) | 4,783 | ||||||||||||||
Total comprehensive loss | (190,546) | 28,539 | (162,007) | ||||||||||||||
Comprehensive loss attributable to non-controlling interest | (127) | — | (127) | ||||||||||||||
Comprehensive loss attributable to stockholders | $ | (190,673) | $ | 28,539 | $ | (162,134) |
News Release |
[7T'>!W%U?:!/_E()Z'F"P0(V+C(ZK;5):O+5N]=LB59KK(MV[(E6]+>
MN[>J5\L5&T+]^" $"&DF$)) $I"!\$%",X0.H9@.-K;O_YZY*ZO O[E#F@;N %6TNI]@[6\\2X:/8%6_XL#)*/
M$\$!L#G <<'@(1AGJ)+J&?+[-X$XOE!B>1Z%_E_">[I!D7M$#%4^5[3M,\KK
M+5)*C4=>SS(8^^ R6O"V">6
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M0WQTO#;%PSA?@%O[&=*40T:SCSPQ!^(
MXP+(U9!O*,EVI$D7T +C*DJ27Z%4$$:J&:0AV6@^CHFZUREV
>AR_^=?VX1:&3L)8-S\NEA:K(6[S"I$W 76Y
M$C;0A!8,%92Q9'SS[P7!JN55$SMA?D)QF^R?,,=NCD/:I\*0U?*K"5]/[.;[
M1! 81OSF.\5OI9;7E7"[XYO_*G1, EX1AX8S &$@CKA-P^(AYT4FIX(P><1N
M>AL&\WN:U_0 1S*ZC^&BJ^\4I1AE
-8?20$3;8T.P
M6BP^0"X99K>]9!:G
U?[! "';+0W@/K)!Z-E9]4-O&
M\YC8&*\>=:APPKBHR]FV75DZH-EVY:*=Z61/BHKV7,^*']_$GNA;N%YI^::O
MP(\5K2E8C"JWWOV5C&_,7Z$#F$@DUU^Y[V*M76\MJV6WEHTRQ@7TFFD#P>B-
M1H> 5IK4G=!9B/1OOMJL6GO*J\W2U]#W:?"JH+9LAM$8=&VV)P_U'/>>+7#E
MSRB4?#A[.%N.MG;V@B<;3#P#V)-L3$S<+.OBF76LJ?4))6D5(#E%/,-5C-6^
M%DP5P^2YDV Y'WS
M?M78-X1-%7JOQ[+R"D\])<'+,FE*"UC$5)K2(0>=7RD&%^!R!XHKEP,>TE9/A)+[&?+,KVS_W^Q4!CS>-Q1==J=$6?#A<1[
M?*>_("I>.9C?^M^>']1*FV :XQ0]>3L#XO@#M%E)ZVVN2_)?6TKBM60?2MNS
M#\6![\S@?R,Y=EO_!5!+ P04 " "1.N%8-2)\L3 # !_"P #P &)W
M+3(P,C0P-C(X+GAS9-U66T_;,!1^YU=X>9Z;2YN21J1( S$A 9NX:+PA)SEI
M+1([LQU:_OULIZ$44J#:-$WCA?B<[SLYEZ\G/CA<5B5Z "$I9XGC#SP'
DE20X#6*L8X2+W Q[YSQ(7@C:5*#&-^UN/5D!X5P \]!>V+'M>M>HSZZ
M7/BJF%$19%(.2(C,$BF[S3F>26("H 8;G:+#IN);YK:>Y..#MP'CH"VM54Z]
MNP@GKIQ#O]7*/'.2>DZXDC@ZI&"ZUYP\81DS63 V2W(8S4U6MQ[JX%!N8#MH
M0ZNK[-[4X/JQWPA<=;. B[2H.Z]X(BX%3:(.3@7)\-]#3X5_S/2FM:UG^>C0
M;6 X:!>K^W%$<7A2E:L=-9RPO4XE$FPJ6YD.[:F4.J-NY*RP17"7
M3*?L ,E5UGV/&$0X@OVVI\&+HI-K@!